PedAM
Pediatric Disease Annotations & Medicines
| Disease | iron deficiency anemia |
| Phenotype | C0022661|chronic renal disease |
| Sentences | 1 |
| PubMedID- 24790431 | Iron oxide-based uspios have been widely used for the characterization of nodal metastasis in various abdomino-pelvic malignancies.22,23 ferumoxytol is a newer uspio, which is fda-approved for the treatment of iron deficiency anemia in patients with chronic renal disease and has also been utilized to image inflammation in animal studies.24–26 another super paramagnetic iron oxide-ferucarbotran was recently studied by kakite et al in animal models to evaluate ablated liver parenchyma.27 this observation was further validated in human studies, which demonstrated the use of impaired clearance of ferucarbotran to assess ablative margin and predict residual or recurrent tumor in patients undergoing radiofrequency ablation for hepatocellular carcinoma.28,29 ferumoxytol has been used for tumor imaging before by muldoon et al for intracerebral tumors in animal models. |
Page: 1